RT Book, Section
A1 Halpern, Dan G.
A1 Sarma, Amy
A1 Economy, Katherine E.
A1 Valente,  Anne Marie
A2 Fuster, Valentin
A2 Narula, Jagat
A2 Vaishnava, Prashant
A2 Leon, Martin B.
A2 Callans, David J.
A2 Rumsfeld, John S.
A2 Poppas, Athena
SR Print(0)
ID 1202453624
T1 Heart Disease in Pregnancy
T2 Fuster and Hurst's The Heart, 15e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264257560
LK accesscardiology.mhmedical.com/content.aspx?aid=1202453624
RD 2024/04/24
AB Chapter  SummaryCardiovascular  disease  (CVD)  complicates  1%  to  4%  of  pregnancies  and  is  the  primary  cause  of  nonobstetric  maternal  mortality.  Older  maternal  age,  with  associated  increases  in  CVD  risk  factors  such  as  obesity,  hypertension,  and  diabetes,  as  well  as  improved  survival  of  patients  with  congenital  heart  disease  have  increased  the  burden  of  CVD  during  pregnancy.  Optimal  patient  care  for  the  pregnant  woman  with  CVD  relies  on  an  understanding  of  the  unique  hemodynamic  changes  of  pregnancy  and  the  pathophysiology,  signs  and  symptoms,  and  natural  history  specific  to  each  heart  condition  that  may  impact  pregnancy.  Preconception  consultation  of  pregnant  women  with  CVD  is  imperative  and  such  individuals  should  be  cared  for  by  expert  multidisciplinary  teams  in  anticipation  of  possible  complications  that  may  arise  during  the  antepartum,  intrapartum,  and  postpartum  periods.  Pregnancy  is  not  advised  in  several  conditions  and  some  medications  are  contraindicated  during  pregnancy  (see  Fuster  and  Hurst’s  Central  Illustration).